Fundz

Mediar Therapeutics reported raising $31.8 Million in an initial SEC Form D filing, from an offering of $31.8 Million

PRIVATEDec 02, 2022

Amount Raised

$31.8 Million

$31.8 Million sold, per SEC Form D (first sale Nov 18, 2022)

Round Type

Venture

CambridgeOtherBiotechnologyHealth Care

Quick answer

Mediar Therapeutics raised $31.8 Million in a funding round, dated November 18, 2022. Mediar Therapeutics is based in Cambridge, Massachusetts, United States.

How much did Mediar Therapeutics raise?
Mediar Therapeutics raised $31.8 Million in a funding round on November 18, 2022.
What does Mediar Therapeutics do?
Mediar Therapeutics is pioneering a new approach to fibrosis treatment that aims to halt the disease at a different source – the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease..
Where is Mediar Therapeutics based and how big is it?
Mediar Therapeutics is based in Cambridge, Massachusetts, United States. Fundz records about 54 employees.
Who are the decision-makers at Mediar Therapeutics?
Fundz holds 4 contacts at Mediar Therapeutics, including the Director, Head of Human Resources. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Mediar Therapeutics that raised within 45 days of this round, from Fundz verified event records.

  • CytoSorbents Corporation raised $5M (Debt Financing) on December 29, 2022.
  • Cue Biopharma raised an undisclosed amount on December 27, 2022.
  • TRACON raised $30M (Grant) on December 27, 2022.
  • Endovia Health Sciences, Inc. raised $4M (Seed) on December 27, 2022.
  • PVmed raised $14M (Series A) on December 23, 2022.
  • GenSight Biologics raised $13M (Convertible Note) on December 23, 2022.

Who to call at Mediar Therapeutics, and when

A new round usually means Mediar Therapeutics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Mediar Therapeutics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Mediar Therapeutics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Mediar Therapeutics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Mediar Therapeutics

Location

20 OVERLAND STREET

Cambridge, Massachusetts, United States

About

Mediar Therapeutics is pioneering a new approach to fibrosis treatment that aims to halt the disease at a different source – the myofibroblast, the key pathogenic cell in fibrosis that drives scarring, disease progression, and ultimately organ failure. Mediar was founded based on a deep understanding of the complex science underlying fibrosis progression. By combining novel targets with reliable, easily detectable blood biomarkers and familiar modalities, Mediar’s goal is to bring forward novel anti-fibrotic therapies that potentially have a precision medicine approach.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Mediar Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Verified contactsAashna G., Director, Head of Human Resources hidden hidden hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Mediar Therapeutics's next move

See what Strategic adds

Mediar Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.